Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Active targeted delivery of immune therapeutics to lymph nodes.

Bahmani B, Vohra I, Kamaly N, Abdi R.

Curr Opin Organ Transplant. 2018 Feb;23(1):8-14. doi: 10.1097/MOT.0000000000000495. Review.

PMID:
29176361
2.

Bioinspired Heparin Nanosponge Prepared by Photo-crosslinking for Controlled Release of Growth Factors.

Choi WI, Sahu A, Vilos C, Kamaly N, Jo SM, Lee JH, Tae G.

Sci Rep. 2017 Oct 30;7(1):14351. doi: 10.1038/s41598-017-14040-5.

3.

Targeted Nanotherapeutics Encapsulating Liver X Receptor Agonist GW3965 Enhance Antiatherogenic Effects without Adverse Effects on Hepatic Lipid Metabolism in Ldlr-/- Mice.

Yu M, Amengual J, Menon A, Kamaly N, Zhou F, Xu X, Saw PE, Lee SJ, Si K, Ortega CA, Choi WI, Lee IH, Bdour Y, Shi J, Mahmoudi M, Jon S, Fisher EA, Farokhzad OC.

Adv Healthc Mater. 2017 Oct;6(20). doi: 10.1002/adhm.201700313. Epub 2017 Jul 21.

4.

Improved Targeting of Cancers with Nanotherapeutics.

Foster C, Watson A, Kaplinsky J, Kamaly N.

Methods Mol Biol. 2017;1530:13-37. doi: 10.1007/978-1-4939-6646-2_2.

PMID:
28150194
5.

Nanomedicines for renal disease: current status and future applications.

Kamaly N, He JC, Ausiello DA, Farokhzad OC.

Nat Rev Nephrol. 2016 Dec;12(12):738-753. doi: 10.1038/nrneph.2016.156. Epub 2016 Oct 31. Review.

6.

Targeted nanoparticles for colorectal cancer.

Cisterna BA, Kamaly N, Choi WI, Tavakkoli A, Farokhzad OC, Vilos C.

Nanomedicine (Lond). 2016 Sep;11(18):2443-56. doi: 10.2217/nnm-2016-0194. Epub 2016 Aug 16. Review.

7.

Self-assembled peptide-based nanostructures: Smart nanomaterials toward targeted drug delivery.

Habibi N, Kamaly N, Memic A, Shafiee H.

Nano Today. 2016 Feb;11(1):41-60.

8.

Targeted Interleukin-10 Nanotherapeutics Developed with a Microfluidic Chip Enhance Resolution of Inflammation in Advanced Atherosclerosis.

Kamaly N, Fredman G, Fojas JJ, Subramanian M, Choi WI, Zepeda K, Vilos C, Yu M, Gadde S, Wu J, Milton J, Carvalho Leitao R, Rosa Fernandes L, Hasan M, Gao H, Nguyen V, Harris J, Tabas I, Farokhzad OC.

ACS Nano. 2016 May 24;10(5):5280-92. doi: 10.1021/acsnano.6b01114. Epub 2016 Apr 28.

9.

Nanomedicines for Endothelial Disorders.

Chung BL, Toth MJ, Kamaly N, Sei YJ, Becraft J, Mulder WJ, Fayad ZA, Farokhzad OC, Kim Y, Langer R.

Nano Today. 2015 Dec 1;10(6):759-776.

10.

Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release.

Kamaly N, Yameen B, Wu J, Farokhzad OC.

Chem Rev. 2016 Feb 24;116(4):2602-63. doi: 10.1021/acs.chemrev.5b00346. Epub 2016 Feb 8. Review. No abstract available.

11.

Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle.

Miller MA, Gadde S, Pfirschke C, Engblom C, Sprachman MM, Kohler RH, Yang KS, Laughney AM, Wojtkiewicz G, Kamaly N, Bhonagiri S, Pittet MJ, Farokhzad OC, Weissleder R.

Sci Transl Med. 2015 Nov 18;7(314):314ra183. doi: 10.1126/scitranslmed.aac6522.

12.

Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice.

Fredman G, Kamaly N, Spolitu S, Milton J, Ghorpade D, Chiasson R, Kuriakose G, Perretti M, Farokzhad O, Tabas I.

Sci Transl Med. 2015 Feb 18;7(275):275ra20. doi: 10.1126/scitranslmed.aaa1065. Erratum in: Sci Transl Med. 2015 Mar 4;7(277):277er2. Farokzhad, Omid [corrected to Farokhzad, Omid].

13.

Annexin A1-containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair.

Leoni G, Neumann PA, Kamaly N, Quiros M, Nishio H, Jones HR, Sumagin R, Hilgarth RS, Alam A, Fredman G, Argyris I, Rijcken E, Kusters D, Reutelingsperger C, Perretti M, Parkos CA, Farokhzad OC, Neish AS, Nusrat A.

J Clin Invest. 2015 Mar 2;125(3):1215-27. doi: 10.1172/JCI76693. Epub 2015 Feb 9.

14.

A solvent-free thermosponge nanoparticle platform for efficient delivery of labile proteins.

Choi WI, Kamaly N, Riol-Blanco L, Lee IH, Wu J, Swami A, Vilos C, Yameen B, Yu M, Shi J, Tabas I, von Andrian UH, Jon S, Farokhzad OC.

Nano Lett. 2014 Nov 12;14(11):6449-55. doi: 10.1021/nl502994y. Epub 2014 Oct 21.

15.

CXCR4-targeted and MMP-responsive iron oxide nanoparticles for enhanced magnetic resonance imaging.

Gallo J, Kamaly N, Lavdas I, Stevens E, Nguyen QD, Wylezinska-Arridge M, Aboagye EO, Long NJ.

Angew Chem Int Ed Engl. 2014 Sep 1;53(36):9550-4. doi: 10.1002/anie.201405442. Epub 2014 Jul 15.

16.

Development of multinuclear polymeric nanoparticles as robust protein nanocarriers.

Wu J, Kamaly N, Shi J, Zhao L, Xiao Z, Hollett G, John R, Ray S, Xu X, Zhang X, Kantoff PW, Farokhzad OC.

Angew Chem Int Ed Engl. 2014 Aug 18;53(34):8975-9. doi: 10.1002/anie.201404766. Epub 2014 Jul 2.

17.

Engineered nanomedicine for myeloma and bone microenvironment targeting.

Swami A, Reagan MR, Basto P, Mishima Y, Kamaly N, Glavey S, Zhang S, Moschetta M, Seevaratnam D, Zhang Y, Liu J, Memarzadeh M, Wu J, Manier S, Shi J, Bertrand N, Lu ZN, Nagano K, Baron R, Sacco A, Roccaro AM, Farokhzad OC, Ghobrial IM.

Proc Natl Acad Sci U S A. 2014 Jul 15;111(28):10287-92. doi: 10.1073/pnas.1401337111. Epub 2014 Jun 30.

18.

Development of therapeutic polymeric nanoparticles for the resolution of inflammation.

Gadde S, Even-Or O, Kamaly N, Hasija A, Gagnon PG, Adusumilli KH, Erakovic A, Pal AK, Zhang XQ, Kolishetti N, Shi J, Fisher EA, Farokhzad OC.

Adv Healthc Mater. 2014 Sep;3(9):1448-1456. doi: 10.1002/adhm.201300688. Epub 2014 Mar 24.

19.

Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.

Bertrand N, Wu J, Xu X, Kamaly N, Farokhzad OC.

Adv Drug Deliv Rev. 2014 Feb;66:2-25. doi: 10.1016/j.addr.2013.11.009. Epub 2013 Nov 22. Review.

20.

Design, synthesis and in vitro characterization of fluorescent and paramagnetic CXCR4-targeted imaging agents.

Tietz O, Kamaly N, Smith G, Shamsaei E, Bhakoo KK, Long NJ, Aboagye EO.

Am J Nucl Med Mol Imaging. 2013 Jul 10;3(4):372-83. Print 2013.

21.

Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles.

Kamaly N, Fredman G, Subramanian M, Gadde S, Pesic A, Cheung L, Fayad ZA, Langer R, Tabas I, Farokhzad OC.

Proc Natl Acad Sci U S A. 2013 Apr 16;110(16):6506-11. doi: 10.1073/pnas.1303377110. Epub 2013 Mar 26.

22.

Targeted polymeric therapeutic nanoparticles: design, development and clinical translation.

Kamaly N, Xiao Z, Valencia PM, Radovic-Moreno AF, Farokhzad OC.

Chem Soc Rev. 2012 Apr 7;41(7):2971-3010. doi: 10.1039/c2cs15344k. Epub 2012 Mar 5. Review.

23.

Copper-free click--a promising tool for pre-targeted PET imaging.

Evans HL, Slade RL, Carroll L, Smith G, Nguyen QD, Iddon L, Kamaly N, Stöckmann H, Leeper FJ, Aboagye EO, Spivey AC.

Chem Commun (Camb). 2012 Jan 25;48(7):991-3. doi: 10.1039/c1cc16220a. Epub 2011 Dec 7.

PMID:
22158912
24.

Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation.

Shi J, Xiao Z, Kamaly N, Farokhzad OC.

Acc Chem Res. 2011 Oct 18;44(10):1123-34. doi: 10.1021/ar200054n. Epub 2011 Jun 21. Review.

PMID:
21692448
25.

Synthesis and characterization of a theranostic vascular disrupting agent for in vivo MR imaging.

Kalber TL, Kamaly N, Higham SA, Pugh JA, Bunch J, McLeod CW, Miller AD, Bell JD.

Bioconjug Chem. 2011 May 18;22(5):879-86. doi: 10.1021/bc100329t. Epub 2011 Apr 7.

PMID:
21410265
26.

Novel multifunctional nanoparticle mediates siRNA tumour delivery, visualisation and therapeutic tumour reduction in vivo.

Kenny GD, Kamaly N, Kalber TL, Brody LP, Sahuri M, Shamsaei E, Miller AD, Bell JD.

J Control Release. 2011 Jan 20;149(2):111-6. doi: 10.1016/j.jconrel.2010.09.020. Epub 2010 Oct 1.

PMID:
20888381
27.

A low molecular weight folate receptor targeted contrast agent for magnetic resonance tumor imaging.

Kalber TL, Kamaly N, So PW, Pugh JA, Bunch J, McLeod CW, Jorgensen MR, Miller AD, Bell JD.

Mol Imaging Biol. 2011 Aug;13(4):653-62. doi: 10.1007/s11307-010-0400-3.

PMID:
20809208
28.

Paramagnetic liposome nanoparticles for cellular and tumour imaging.

Kamaly N, Miller AD.

Int J Mol Sci. 2010 Apr 15;11(4):1759-76. doi: 10.3390/ijms11041759. Review.

29.

Chemistry of tumour targeted T1 based MRI contrast agents.

Kamaly N, Miller AD, Bell JD.

Curr Top Med Chem. 2010;10(12):1158-83. Review.

PMID:
20388110
30.

A novel bimodal lipidic contrast agent for cellular labelling and tumour MRI.

Kamaly N, Kalber T, Kenny G, Bell J, Jorgensen M, Miller A.

Org Biomol Chem. 2010 Jan 7;8(1):201-11. doi: 10.1039/b910561a. Epub 2009 Nov 5.

PMID:
20024151
31.

DODAG; a versatile new cationic lipid that mediates efficient delivery of pDNA and siRNA.

Mével M, Kamaly N, Carmona S, Oliver MH, Jorgensen MR, Crowther C, Salazar FH, Marion PL, Fujino M, Natori Y, Thanou M, Arbuthnot P, Yaouanc JJ, Jaffrès PA, Miller AD.

J Control Release. 2010 Apr 19;143(2):222-32. doi: 10.1016/j.jconrel.2009.12.001. Epub 2009 Dec 5.

PMID:
19969034
32.

Imaging of gadolinium spatial distribution in tumor tissue by laser ablation inductively coupled plasma mass spectrometry.

Kamaly N, Pugh JA, Kalber TL, Bunch J, Miller AD, McLeod CW, Bell JD.

Mol Imaging Biol. 2010 Aug;12(4):361-6. doi: 10.1007/s11307-009-0282-4. Epub 2009 Nov 17.

PMID:
19921340
33.

Folate receptor targeted bimodal liposomes for tumor magnetic resonance imaging.

Kamaly N, Kalber T, Thanou M, Bell JD, Miller AD.

Bioconjug Chem. 2009 Apr;20(4):648-55. doi: 10.1021/bc8002259.

PMID:
19368341
34.

Bimodal paramagnetic and fluorescent liposomes for cellular and tumor magnetic resonance imaging.

Kamaly N, Kalber T, Ahmad A, Oliver MH, So PW, Herlihy AH, Bell JD, Jorgensen MR, Miller AD.

Bioconjug Chem. 2008 Jan;19(1):118-29. Epub 2007 Nov 7.

PMID:
17985841
35.

MAGfect: a novel liposome formulation for MRI labelling and visualization of cells.

Oliver M, Ahmad A, Kamaly N, Perouzel E, Caussin A, Keller M, Herlihy A, Bell J, Miller AD, Jorgensen MR.

Org Biomol Chem. 2006 Sep 21;4(18):3489-97. Epub 2006 Aug 15.

PMID:
17036144

Supplemental Content

Loading ...
Support Center